⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma

Official Title: A Prospective, Single-arm, Multi-center Clinical Study of Camrelizumab and Chemotherapy Combined With Endoscopic Surgery in the Treatment of Recurrent Nasopharyngeal Carcinoma

Study ID: NCT05011227

Study Description

Brief Summary: To explore the effect of Camrelizumab and chemotherapy combining with endoscopic surgery in the treatment of recurrent nasopharyngeal carcinoma.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Fujian Medical University Union Hospital, Fuzhou, Fujian, China

Fujian Provincial Hospital, Fuzhou, Fujian, China

Shenzhen Second People's Hospital, Shenzhen, Guangdong, China

The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China

The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

Eye& ENT Hospital, Fudan University, Shanghai, Shanghai, China

Shanghai Zhongshan Hospital,Fudan University, Shanghai, Shanghai, China

Contact Details

Name: Hongmeng Yu, MD,PHD

Affiliation: Eye&ENT Hospital,Fudan University

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: